GKB Ophthalmics Faces Shareholder Criticism at Virtual AGM
GKB Ophthalmics Ltd held its 43rd Annual General Meeting (AGM) virtually on August 21, 2025. The meeting was marked by controversy when shareholder Abhishek Kalra, owning one share, verbally attacked the company's management. Kalra criticized Managing Director Krishna Gopal Gupta's performance and demanded his resignation within 10 days. The confrontation occurred against a backdrop of weak stock performance, with shares declining 32.27% over the past year and 18.38% year-to-date. Despite the incident, the AGM proceeded with its agenda, passing several resolutions including financial statement adoption, director re-appointment, and approval of related party transactions. The meeting saw participation from 55 shareholders, with all resolutions passed by the requisite majority.

*this image is generated using AI for illustrative purposes only.
GKB Ophthalmics Ltd, a player in the ophthalmic industry, recently held its 43rd Annual General Meeting (AGM) amid controversy as a shareholder with a single share launched a verbal attack on the company's management.
Shareholder Confrontation
The virtual AGM, held on August 21, 2025, became the center of attention when investor Abhishek Kalra, owning just one share, confronted the company's leadership. Kalra directed his criticism at Managing Director Krishna Gopal Gupta, questioning his performance despite claiming 40 years of experience in the ophthalmic industry.
Allegations and Demands
Kalra alleged that Gupta's corporate bodies abroad have never delivered profits. In a bold move, the shareholder demanded Gupta's resignation within 10 days and made personal remarks about his leadership.
Stock Performance Concerns
The confrontation comes against a backdrop of weak stock performance for GKB Ophthalmics. The company's shares have seen a significant decline:
Period | Decline |
---|---|
Past year | 32.27% |
Year-to-date | 18.38% |
However, there has been a recent recovery, with the stock showing a 10.51% increase over the past three months.
AGM Proceedings
Despite the confrontation, the AGM proceeded with its agenda. The meeting, conducted through video conferencing, saw the passage of several resolutions:
- Adoption of Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2025
- Re-appointment of Mr. Cedric Lobo as a director
- Appointment of Ms. Girija Nagvekar as Secretarial Auditor
- Approval of material related party transactions
- Fresh approval of the company's borrowing limit
- Creation of mortgages/charges on the company's assets
All resolutions were passed with the requisite majority, with 100% of the votes cast in favor for most items.
Shareholder Participation
The AGM saw participation from 55 shareholders, including 6 from the promoter and promoter group, and 49 from the public. The total number of votes polled varied for different resolutions, ranging from 161,904 to 869,997 votes.
While the shareholder's outburst has drawn attention to GKB Ophthalmics, the company continues to navigate its business operations amidst these challenges. The management's response to the criticism and its plans to address the stock performance concerns remain to be seen.
Historical Stock Returns for GKB Ophthalmics
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+1.39% | -2.25% | +9.56% | -2.21% | -34.04% | +62.20% |